探索基因与患者的关联,以通过线性邻里传播来识别个性化癌症驱动基因
Yiran Huang1,2,3, Fuhao Chen1, Hongtao Sun1
1School of Computer, Electronics and Information, Guangxi University, Nanning, 530004, China.
BMC bioinformatics
|January 23, 2024
概括
LPDriver使用一种新的线性邻里传播模型来识别个性化癌症驱动基因. 这种方法通过分析个体遗传数据和基因与患者的关联,准确地检测驱动基因,改善癌症诊断和治疗.
科学领域:
- 计算生物学是一种计算生物学.
- 癌症基因组学 癌症基因组学
- 生物信息学是一种生物信息学.
背景情况:
- 驱动基因对于癌症的发展,诊断和理解至关重要.
- 瘤异质性在识别个性化的驱动基因方面存在挑战.
- 现有的计算方法往往忽略了基因与患者的关联,以实现个性化的驱动基因发现.
研究的目的:
- 提出LPDriver,一种用于识别个性化癌症驱动基因的新方法.
- 为了利用个人遗传数据和基因-患者协会进行驱动基因检测.
- 解决目前针对个性化癌症基因组学的方法的局限性.
主要方法:
- 开发了LPDriver,使用线性邻里传播模型.
- 从个体患者的遗传数据构建个性化的基因网络.
- 从个性化网络的双边图表中提取和分析基因-患者关联.
主要成果:
- 与现有方法相比,LPDriver的性能具有竞争力.
- 该方法准确地预测了个性化的癌症驱动基因.
- 识别了基于网络特征的新型驱动基因和个性化的驱动程序,即使有隐藏的突变数据.
结论:
- LPDriver为预测个性化癌症驱动基因提供了一种有效的方法.
- 这种方法有可能推进癌症诊断和治疗策略.
- 源代码和数据是公开可用的,用于可复制性和进一步研究.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


